Tag: ATTRACT
DEFIANCE randomized controlled trial set to provide best assessment of mechanical...
NOTE: This video is ONLY available to watch in selected countries and geographies
David Dexter, (Sentara Vascular Specialists, Norfolk, USA, National Co-PI of the...
Mechanical thrombectomy for DVT: Randomised data needed to boost growing evidence...
Two datasets presented during the late-breaking clinical trials session at The VEINS (Venous Endovascular Interventional Strategies) 2022 (30–31 October, Las Vegas, USA)—the latest results...
New developments in treatment of deep vein thrombosis
An analysis of ATTRACT has recently been published in the journal Circulation, in which the authors examine the effect of pharmacomechanical catheter-directed therapy (PCDT) in ATTRACT patients...
CX audience rejects idea that ATTRACT has the final say on...
According to a debate at the Charing Cross Symposium (CX; 24–27 April, London, UK), the vast majority of CX delegates disagree with the view...
Setting the record straight: Clarifying the misconceptions of the ATTRACT trial
A special session during the pre-conference Day of Innovation and Science at the American Venous Forum annual meeting (AVF; 20–23 February, Tucson, USA) presented...
Published ATTRACT data call into question validity of the Villalta scale
Following the publication of the ATTRACT trial in the New England Journal of Medicine (NEJM) in December 2017, Venous News spoke to experts in...
ATTRACT results are “a springboard” for future pharmacomechanical thrombolysis research
Data from the randomised controlled ATTRACT trial revealed that the addition of catheter-based intervention to standard-of-care anticoagulation failed to significantly decrease the occurrence of...
ATTRACT fails to meet primary endpoint, but experts agree results are...
Data from the randomised controlled ATTRACT trial revealed that the addition of catheter-based intervention to standard-of-care anticoagulation failed to significantly decrease the occurrence of...